Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Moro

Showing results (71-80 of 292) with videos related to

Pageof 30
Sort By:
Biomolecules|May 13, 2020
New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics SimulationsGiovanni Bolcato, Maicol Bissaro, Giuseppe Deganutti, et al.
Frontiers in Molecular Biosciences|September 17, 2021
Shedding Light on the Molecular Recognition of Sub-Kilodalton Macrocyclic Peptides on Thrombin by Supervised Molecular DynamicsMahdi Hassankalhori, Giovanni Bolcato, Maicol Bissaro, et al.
International Journal of Molecular Sciences|July 24, 2019
Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind DatabaseGiovanni Bolcato, Alberto Cuzzolin, Maicol Bissaro, et al.
Cells|October 28, 2025
Adenosine Receptors in Neuroinflammation and NeurodegenerationVeronica Salmaso, Silvia Menin, Stefano Moro, et al.
Molecules (Basel, Switzerland)|June 3, 2015
DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening SimulationsAlberto Cuzzolin, Mattia Sturlese, Ivana Malvacio, et al.
Medicinal Research Reviews|December 29, 2005
Progress in the pursuit of therapeutic adenosine receptor antagonistsStefano Moro, Zhan-Guo Gao, Kenneth A Jacobson, et al.
Biomedicines|February 25, 2022
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism?Giovanni Bolcato, Matteo Pavan, Davide Bassani, et al.
Journal of Agricultural and Food Chemistry|August 29, 2012
Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: an in vitro studyValentina Furlanetto, Giuseppe Zagotto, Riccardo Pasquale, et al.
Trends in Pharmacological Sciences|November 6, 2015
Advances in Computational Techniques to Study GPCR-Ligand RecognitionAntonella Ciancetta, Davide Sabbadin, Stephanie Federico, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M<sup>pro</sup>Davide Bassani, Matteo Pavan, Giovanni Bolcato, et al.
Pageof 30

Showing results (71-80 of 292) with videos related to

Sort By:
Pageof 30
Biomolecules|May 13, 2020
New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics SimulationsGiovanni Bolcato, Maicol Bissaro, Giuseppe Deganutti, et al.
Frontiers in Molecular Biosciences|September 17, 2021
Shedding Light on the Molecular Recognition of Sub-Kilodalton Macrocyclic Peptides on Thrombin by Supervised Molecular DynamicsMahdi Hassankalhori, Giovanni Bolcato, Maicol Bissaro, et al.
International Journal of Molecular Sciences|July 24, 2019
Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind DatabaseGiovanni Bolcato, Alberto Cuzzolin, Maicol Bissaro, et al.
Cells|October 28, 2025
Adenosine Receptors in Neuroinflammation and NeurodegenerationVeronica Salmaso, Silvia Menin, Stefano Moro, et al.
Molecules (Basel, Switzerland)|June 3, 2015
DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening SimulationsAlberto Cuzzolin, Mattia Sturlese, Ivana Malvacio, et al.
Medicinal Research Reviews|December 29, 2005
Progress in the pursuit of therapeutic adenosine receptor antagonistsStefano Moro, Zhan-Guo Gao, Kenneth A Jacobson, et al.
Biomedicines|February 25, 2022
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism?Giovanni Bolcato, Matteo Pavan, Davide Bassani, et al.
Journal of Agricultural and Food Chemistry|August 29, 2012
Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: an in vitro studyValentina Furlanetto, Giuseppe Zagotto, Riccardo Pasquale, et al.
Trends in Pharmacological Sciences|November 6, 2015
Advances in Computational Techniques to Study GPCR-Ligand RecognitionAntonella Ciancetta, Davide Sabbadin, Stephanie Federico, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M<sup>pro</sup>Davide Bassani, Matteo Pavan, Giovanni Bolcato, et al.
Pageof 30